Dr. Robert Be, M.D

NPI: 1417923970
Total Payments
$6,768
2024 Payments
$857.62
Companies
43
Transactions
443
Medicare Patients
2,745
Medicare Billing
$443,357

Payment Breakdown by Category

Food & Beverage$6,734 (99.5%)
Education$34.05 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,734 436 99.5%
Education $34.05 3 0.5%
Unspecified $0 4 0.0%

Payments by Type

General
$6,768
439 transactions
Ownership
$0
4 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,768 120 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $575.85 41 $0 (2024)
Janssen Biotech, Inc. $565.63 41 $0 (2024)
Celgene Corporation $502.65 36 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $497.92 33 $0 (2023)
Ferring Pharmaceuticals Inc. $344.93 25 $0 (2023)
Daiichi Sankyo Inc. $200.82 10 $0 (2023)
Ardelyx, Inc. $182.03 9 $0 (2024)
Intercept Pharmaceuticals, Inc. $163.74 11 $0 (2021)
Allergan Inc. $135.80 9 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $857.62 57 ABBVIE INC. ($253.90)
2023 $735.53 43 AbbVie Inc. ($273.98)
2022 $1,161 76 ABBVIE INC. ($283.48)
2021 $761.30 54 AbbVie Inc. ($258.11)
2020 $543.99 38 Janssen Biotech, Inc. ($148.83)
2019 $937.38 62 AbbVie, Inc. ($249.40)
2018 $873.64 57 AbbVie, Inc. ($184.18)
2017 $897.33 56 AbbVie, Inc. ($189.38)

All Payment Transactions

443 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/17/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $24.65 General
Category: INFLAMMATION AND IMMUNOLOGY
12/12/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.69 General
Category: Immunology
12/11/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $24.67 General
Category: LIVER DISEASE
12/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.98 General
Category: GASTROENTEROLOGY
11/27/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $6.59 General
Category: IMMUNOLOGY
11/27/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $0.69 General
Category: IMMUNOLOGY
11/26/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $18.61 General
Category: Sacral Nerve Stimulation
11/20/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $28.68 General
Category: IMMUNOLOGY
11/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $4.16 General
Category: IMMUNOLOGY
11/19/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $28.57 General
Category: LIVER DISEASE
11/01/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $14.45 General
Category: GASTROENTEROLOGY
10/29/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $13.27 General
Category: INTERNAL MEDICINE
10/24/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.19 General
Category: IMMUNOLOGY
10/22/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $20.21 General
Category: ONCOLOGY
10/16/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $13.71 General
Category: Sacral Nerve Stimulation
10/15/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $16.32 General
Category: INTERNAL MEDICINE
09/30/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.83 General
Category: Immunology
09/25/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $27.08 General
Category: ONCOLOGY
09/24/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $18.97 General
Category: Immunology
09/23/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $7.24 General
Category: IMMUNOLOGY
09/10/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $20.00 General
Category: Neuroscience
09/05/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $13.70 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/22/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $14.19 General
Category: INTERNAL MEDICINE
08/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.52 General
Category: IMMUNOLOGY
08/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $12.70 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 712 2,688 $410,853 $94,463
2022 23 766 9,817 $894,180 $213,911
2021 22 729 2,514 $349,357 $80,268
2020 14 538 2,923 $260,084 $54,716
Total Patients
2,745
Total Services
17,942
Medicare Billing
$443,357
Procedure Codes
80

All Medicare Procedures & Services

80 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 45 478 $72,656 $16,651 22.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 82 82 $87,430 $16,591 19.0%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 44 269 $26,900 $12,424 46.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 115 151 $22,348 $8,652 38.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 29 29 $22,562 $5,073 22.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 43 49 $10,633 $4,386 41.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 43 44 $12,712 $4,298 33.8%
91010 Study of esophagus to assess movement Office 2023 21 21 $11,508 $3,135 27.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 47 49 $34,464 $2,930 8.5%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 25 27 $18,927 $2,872 15.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 40 40 $33,880 $2,737 8.1%
91037 Monitoring and recording of esophageal function through nasal tube with electrode Office 2023 21 21 $7,350 $2,527 34.4%
91122 Study of rectum sensitivity and function Office 2023 12 12 $5,664 $2,377 42.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 16 16 $5,312 $1,878 35.4%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 23 24 $13,077 $1,875 14.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 30 $4,620 $1,845 39.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 26 26 $5,723 $1,620 28.3%
44361 Biopsy of small bowel (except ileum) using an endoscope Facility 2023 11 11 $7,370 $863.75 11.7%
76700 Complete ultrasound scan of abdomen Office 2023 16 16 $4,220 $841.95 20.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 16 19 $1,586 $736.13 46.4%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 11 1,274 $1,911 $149.72 7.8%
J3380 Injection, vedolizumab, 1 mg Office 2022 15 6,000 $408,000 $105,858 25.9%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 45 689 $104,576 $23,512 22.5%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 46 366 $36,600 $16,461 45.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 69 70 $74,205 $12,845 17.3%

About Dr. Robert Be, M.D

Dr. Robert Be, M.D is a Gastroenterology healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417923970.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Be, M.D has received a total of $6,768 in payments from pharmaceutical and medical device companies, with $857.62 received in 2024. These payments were reported across 443 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,734).

As a Medicare-enrolled provider, Be has provided services to 2,745 Medicare beneficiaries, totaling 17,942 services with total Medicare billing of $443,357. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Baton Rouge, LA
  • Active Since 02/24/2006
  • Last Updated 11/07/2014
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1417923970

Products in Payments

  • ZEPOSIA (Drug) $502.65
  • STELARA (Biological) $456.64
  • ENTYVIO (Biological) $359.22
  • RINVOQ (Biological) $338.18
  • XIFAXAN (Drug) $329.87
  • LINZESS (Drug) $261.11
  • Humira (Biological) $227.08
  • CLENPIQ (Drug) $221.99
  • Mavyret (Drug) $213.91
  • IBSRELA (Drug) $182.03
  • INJECTAFER (Drug) $175.39
  • Dexilant (Drug) $164.89
  • HUMIRA (Biological) $125.09
  • CREON (Drug) $118.98
  • Creon (Drug) $114.89
  • Trulance (Drug) $107.16
  • OCALIVA (Drug) $106.14
  • Linzess (Drug) $98.87
  • Alinia Tablets 500mg 30 count bottle (Drug) $98.03
  • MAVYRET (Drug) $97.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Baton Rouge